Cargando…
Progress on COVID-19 Chemotherapeutics Discovery and Novel Technology
COVID-19 is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a novel highly contagious and pathogenic coronavirus that emerged in late 2019. SARS-CoV-2 spreads primarily through virus-containing droplets and small particles of air pollution, which greatly...
Autores principales: | Zhou, Yalan, Wang, Huizhen, Yang, Li, Wang, Qingzhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9736643/ https://www.ncbi.nlm.nih.gov/pubmed/36500347 http://dx.doi.org/10.3390/molecules27238257 |
Ejemplares similares
-
Progression of Antiviral Agents Targeting Viral Polymerases
por: Peng, Siqi, et al.
Publicado: (2022) -
Research progress of anti-glioma chemotherapeutic drugs
por: Zhou, Yi-Shu, et al.
Publicado: (2022) -
Identification of novel targets and pathways to distinguish suicide dependent or independent on depression diagnosis
por: Peng, Siqi, et al.
Publicado: (2023) -
Natural Products as a Vital Source for the Discovery of Cancer Chemotherapeutic and Chemopreventive Agents
por: Cragg, Gordon M., et al.
Publicado: (2016) -
Application of microfluidic technologies on COVID-19 diagnosis and drug discovery
por: Lin, Zhun, et al.
Publicado: (2023)